Stockholm, Sweden

ESTRO 2026

Session

Monday
May 18
15:15 - 16:15
K11
Brachytherapy 3
Dina Najjari Jamal, Spain;
Georgina Fröhlich, Hungary
Poster Discussions
Brachytherapy
15:15 - 16:15
Brachytherapy in Ukraine: Survey-Based Assessment of Current Status, Challenges, and Formation of the Collegium of Ukrainian Brachytherapy
Serhii Brovchuk, Ukraine
-4661
15:15 - 16:15
OSIRIS-BOT:  Organ Sparing using Interventional Radiotherapy (Brachytherapy) for early Invasive Squamous cell cancer of the Base of Tongue
Tamer Soror, Germany
-320
15:15 - 16:15
SBRT with HDR boost vs SBRT alone: a prospective comparative analysis of side effects, quality of life and disease control.
Laura Zaragoza Cocero, Spain
-3481
15:15 - 16:15
From Seeds to SABR: Insights from LDR Brachytherapy Dose Patterns to Guide Prostate Focal Boost Strategies
David Quigley, United Kingdom
-539
15:15 - 16:15
CT-based versus TRUS-based High-Dose-Rate brachytherapy boost in prostate cancer: long-term oncological outcomes
Alai Goñi Ramirez, Spain
-1670
15:15 - 16:15
Oncologic outcome and toxicity after focal salvage HDR brachytherapy in locally recurrent prostate cancer after radiotherapy
Marnix Rasing, The Netherlands
-1099
15:15 - 16:15
Long-term outcomes of HDR brachytherapy as monotherapy for localized prostate cancer: a single-institution experience
Miren Gaztañaga, Spain
-500
15:15 - 16:15
Permanent implant prostate brachytherapy 3D dosimetric reference datasets for model-based dose calculations
Javier Vijande, Spain
-965
15:15 - 16:15
New phantom for fast dosimetric quality assurance of ophthalmic Ru-106 / Rh-106 applicators
Anna Rintala, Finland
-660
15:15 - 16:15
Evaluation of an AI-assisted scan-to-plan workflow for MRI-guided cervical HDR brachytherapy
Renzo Scholman, The Netherlands
-4237